Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643.

Peroxisome proliferators (PPs) are an important class of chemicals that act as hepatic tumor promoters in laboratory rodents. The key target for PPs is the nuclear receptor peroxisome proliferator-activated receptor-alpha (PPARalpha) and these chemicals cause cancer by altering the expression of a subset of genes involved in cell growth regulation. The purpose of the present study was to utilize high-density gene expression arrays to examine the genes regulated by the potent PP Wy14,643 (50 microM, 6 h) in both rat (FaO) and human (HepG2) hepatoma cells. Treatment of FaO cells, but not HepG2, revealed the expected fatty acid catabolism genes. However, a larger than expected number of protein kinases, phosphatases, and signaling molecules were also affected exclusively in the FaO cells, including MAPK-phosphatase 1 (MKP-1), Janus-activated kinases 1 and 2 (JAK1 and 2), and glycogen synthetase kinase alpha and beta (GSKalpha and beta). The mRNA accumulation of these genes as well as the protein level for GSK3alpha, JAK1, and JAK2 and MKP-1 activity was corroborated. Due to the importance of MKP-1 in cell signaling, this induction was examined further and was found to be controlled, at least in part, at the level of the gene's promoter. Interestingly, overexpression of MKP-1 in turn affected the constitutive activity of PPARalpha. Taken together, the gene expression arrays revealed an important subset of PP-regulated genes to be kinases and phosphatases. These enzymes not only would affect growth factor signaling and cell cycle control but also could represent feedback control mechanisms and modulate the activity of PPARalpha.

[1]  Lee Bennett,et al.  Gene expression analysis reveals chemical-specific profiles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  G. Zhou,et al.  Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor γ* , 1996, The Journal of Biological Chemistry.

[3]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[4]  S. Ryser,et al.  MAP Kinase Phosphatase-1 Gene Transcription in Rat Neuroendocrine Cells Is Modulated by a Calcium-sensitive Block to Elongation in the First Exon* , 2001, The Journal of Biological Chemistry.

[5]  M. Comalada,et al.  Protein Kinase Cε Is Required for the Induction of Mitogen-Activated Protein Kinase Phosphatase-1 in Lipopolysaccharide-Stimulated Macrophages1 , 2000, The Journal of Immunology.

[6]  Qingbo Xu,et al.  Induction of Mitogen-activated Protein Kinase Phosphatase-1 by Arachidonic Acid in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[7]  T. Kadowaki,et al.  Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. , 1999, Biochemical and biophysical research communications.

[8]  D. Waxman,et al.  Cross-talk between Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) and Peroxisome Proliferator-activated Receptor-α (PPARα) Signaling Pathways , 1999, The Journal of Biological Chemistry.

[9]  C. Dive,et al.  Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. , 1993, Journal of cell science.

[10]  Barry M. Forman,et al.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .

[11]  K. Motojima,et al.  A protein histidine kinase induced in rat liver by peroxisome proliferators. In vitro activation by Ras protein and guanine nucleotides. , 1993, FEBS letters.

[12]  S. Tafuri,et al.  Regulation of Peroxisome Proliferator-activated Receptor γ Activity by Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[13]  L. Lau,et al.  Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phosphorylation. , 1997, Endocrinology.

[14]  N. Latruffe,et al.  Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines. , 1995, European journal of biochemistry.

[15]  Map kinase phosphatases (MKP's) are early responsive genes during induction of cerulein hyperstimulation pancreatitis. , 2000 .

[16]  M. Gabrielsen,et al.  Distinct Binding Determinants for ERK2/p38α and JNK MAP Kinases Mediate Catalytic Activation and Substrate Selectivity of MAP Kinase Phosphatase-1* 210 , 2001, The Journal of Biological Chemistry.

[17]  F. Schliess,et al.  Glucagon-induced expression of the MAP kinase phosphatase MKP-1 in rat hepatocytes. , 2000, Gastroenterology.

[18]  J. Capone,et al.  Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Y. Hsu,et al.  Cycloheximide-induced cPLA(2) activation is via the MKP-1 down-regulation and ERK activation. , 2000, Cellular signalling.

[20]  J. Capone,et al.  Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Orphanides,et al.  Downregulation of Lactoferrin by PPARα Ligands: Role in Perturbation of Hepatocyte Proliferation and Apoptosis , 2002 .

[22]  P Fenner-Crisp,et al.  Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.

[23]  J. V. Vanden Heuvel,et al.  Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. , 1999, Journal of lipid research.

[24]  V. Noé,et al.  Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration. , 2000, Molecular pharmacology.

[25]  I. Issemann,et al.  The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. , 1992, The EMBO journal.

[26]  S. Green.  Peroxisome proliferators: a model for receptor mediated carcinogenesis. , 1992, Cancer surveys.

[27]  J. Xaus,et al.  Macrophage colony-stimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. , 1999, Journal of immunology.

[28]  N. Latruffe,et al.  Protein Phosphorylation by Peroxisome Proliferators: Species‐specific Stimulation of Protein Kinases and Its Role in PP‐induced Transcriptional Activation a , 1996, Annals of the New York Academy of Sciences.

[29]  A. Kraft,et al.  Conditional Expression of the Mitogen-activated Protein Kinase (MAPK) Phosphatase MKP-1 Preferentially Inhibits p38 MAPK and Stress-activated Protein Kinase in U937 Cells* , 1997, The Journal of Biological Chemistry.

[30]  M. Rao,et al.  Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. , 2001, Gene expression.

[31]  W. Wahli,et al.  The peroxisome proliferator‐activated receptor α regulates amino acid metabolism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  D J Dix,et al.  Application of DNA arrays to toxicology. , 1999, Environmental health perspectives.

[33]  S. Gill,et al.  Effect of a peroxisome proliferator on 3β-hydroxysteroid dehydrogenase , 2002 .

[34]  M. Southey,et al.  Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. , 2001, Cancer research.

[35]  K. Griffin,et al.  Peroxisome proliferator activated receptor-alpha expression in human liver. , 1998, Molecular pharmacology.

[36]  S. Duclos,et al.  Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate. , 1997, European journal of cell biology.

[37]  G. Williams,et al.  Chemical carcinogen mechanisms of action and implications for testing methodology. , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[38]  M Schena,et al.  Microarrays: biotechnology's discovery platform for functional genomics. , 1998, Trends in biotechnology.

[39]  C. Dive,et al.  Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin , 1994, The Journal of cell biology.

[40]  J. Trent,et al.  Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.

[41]  D. Maysinger,et al.  MKP-1 as a target for pharmacological manipulations in PC12 cell survival , 2001, Neurochemistry International.

[42]  B Staels,et al.  A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. , 1999, Molecular endocrinology.

[43]  J. Peters,et al.  Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. , 1997, Carcinogenesis.

[44]  D. Morris,et al.  Revolution through Genomics in Investigative and Discovery Toxicology , 1999, Toxicologic pathology.

[45]  Yan-Lin Guo,et al.  Resistance to TNF-α cytotoxicity can be achieved through different signaling pathways in rat mesangial cells. , 1999, American journal of physiology. Cell physiology.

[46]  Karim Benkirane,et al.  Vascular and Cardiac Effects in Hypertension , 2022 .

[47]  D. Bandyopadhyay,et al.  Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: a mechanism for the feedback inhibition of insulin signaling. , 1997, Molecular endocrinology.

[48]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[49]  B. Ledwith,et al.  Peroxisome Proliferators Activate Extracellular Signal-regulated Kinases in Immortalized Mouse Liver Cells* , 1997, The Journal of Biological Chemistry.

[50]  V. Faundez,et al.  Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. , 1993, European journal of biochemistry.

[51]  M. Pray-Grant,et al.  Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. , 1998, Molecular pharmacology.

[52]  N. Macdonald,et al.  Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. , 2000, Toxicology letters.

[53]  F. Balkwill,et al.  Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism , 2001, European journal of immunology.

[54]  J. Kuromitsu,et al.  Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists. , 2002, Biochemical and biophysical research communications.

[55]  K. Seta,et al.  Hypoxia-induced Regulation of MAPK Phosphatase-1 as Identified by Subtractive Suppression Hybridization and cDNA Microarray Analysis* , 2001, The Journal of Biological Chemistry.

[56]  R. Davis,et al.  Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Giaccia,et al.  Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) Expression Is Induced by Low Oxygen Conditions Found in Solid Tumor Microenvironments , 1999, The Journal of Biological Chemistry.

[58]  Hong Sun,et al.  MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.

[59]  H. K. Bojes,et al.  Wy-14,643 stimulates hepatic protein kinase C activity. , 1992, Toxicology letters.

[60]  W. Wahli,et al.  Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. , 2000, Molecular endocrinology.

[61]  D. Waxman,et al.  STAT5b Down-regulates Peroxisome Proliferator-activated Receptor α Transcription by Inhibition of Ligand-independent Activation Function Region-1trans-Activation Domain* , 1999, The Journal of Biological Chemistry.

[62]  D. Bandyopadhyay,et al.  Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity , 1997 .

[63]  J. Heuvel.  Peroxisome Proliferator–Activated Receptors: A Critical Link among Fatty Acids, Gene Expression and Carcinogenesis , 1999 .

[64]  B. Lake,et al.  Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium , 1991 .

[65]  N. Galjart,et al.  Identification of a novel peroxisome proliferator responsive cDNA isolated from rat hepatocytes as the zinc-finger protein ZFP-37. , 1998, Toxicology and applied pharmacology.

[66]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[67]  M. Sadar.  Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways* , 1999, The Journal of Biological Chemistry.

[68]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[69]  J. Kusari,et al.  Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK) , 2001, Molecular and Cellular Biochemistry.

[70]  J. Heuvel.  Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. , 1999 .

[71]  A. Atfi,et al.  Insulin-Mediated Cell Proliferation and Survival Involve Inhibition of c-Jun N-terminal Kinases through a Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase Phosphatase-1-Dependent Pathway. , 2000, Endocrinology.

[72]  J. V. Vanden Heuvel,et al.  Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. , 1996, Archives of biochemistry and biophysics.

[73]  E. Lock,et al.  Biochemical mechanisms of induction of hepatic peroxisome proliferation. , 1989, Annual review of pharmacology and toxicology.

[74]  M. Lazar,et al.  Transcriptional Activation by Peroxisome Proliferator-activated Receptor γ Is Inhibited by Phosphorylation at a Consensus Mitogen-activated Protein Kinase Site* , 1997, The Journal of Biological Chemistry.

[75]  M. Manteuffel-Cymborowska.  Nuclear receptors, their coactivators and modulation of transcription. , 1999, Acta biochimica Polonica.

[76]  T. Honda,et al.  mkp-1 Encoding Mitogen-Activated Protein Kinase Phosphatase 1, a Verotoxin 1 Responsive Gene, Detected by Differential Display Reverse Transcription-PCR in Caco-2 Cells , 2000, Infection and Immunity.

[77]  K. Umesono,et al.  Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.

[78]  W. Wahli,et al.  The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. , 1996, Endocrinology.